NCT06639074 2025-10-02
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
1 trialsPhase 2 × Advanced Fallopian Tube Carcinoma × Diphtheria-Tetanus-acellular Pertussis Vaccines × Clear all